Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
Merck settles lawsuit over delayed study results
Merck settles lawsuit over delayed study results
Yahoo/AP
Merck
settlements
Vytorin
2 Eli Lilly FDA Plays With Great Potential And Limited Downside
2 Eli Lilly FDA Plays With Great Potential And Limited Downside
Seeking Alpha
Eli Lilly
FDA
solanezumab
Alzheimer's disease
HGSI Narrows 4Q Loss, Benlysta Grows
HGSI Narrows 4Q Loss, Benlysta Grows
Yahoo/Zacks
earnings
Human Genome Sciences
Why Eli Lilly's Earnings Are Outstanding
Why Eli Lilly's Earnings Are Outstanding
Motley Fool
earnings
Eli Lilly
Will FDA Delay Approving The Eliquis Bloodthinner?
Will FDA Delay Approving The Eliquis Bloodthinner?
Pharmalot
FDA
bloodthinners
Eliquis
Threshold Pharmaceuticals: Understanding The Recent Data
Threshold Pharmaceuticals: Understanding The Recent Data
Seeking Alpha
Threshold Pharmaceuticals
TH-302
pancreatic cancer
ViroPharma Beats Up on Analysts Yet Again
ViroPharma Beats Up on Analysts Yet Again
Motley Fool
ViroPharma
earnings
Why Illumina's Earnings Are Outstanding
Why Illumina's Earnings Are Outstanding
Motley Fool
Illumina
earnings
Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Arena Pharmaceuticals' Lorcaserin Will Be A Blockbuster Drug
Seeking Alpha
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
obesity
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »